Expression of p53 protein isoforms predicts survival in patients with multiple myeloma-Reference-Cited by-同舟云学术

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

Published:2022-03 Issue:6 Volume:97 Page:700-710
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Rojas Elizabeta A.¹²^ORCID,Corchete Luis A.¹²^ORCID,De Ramón Cristina¹^ORCID,Krzeminski Patryk¹²³^ORCID,Quwaider Dalia¹²,García‐Sanz Ramón¹²⁴⁵,Martínez‐López Joaquín⁴⁵⁶⁷^ORCID,Oriol Albert⁵⁸,Rosiñol Laura⁵⁹,Bladé Joan⁵⁹,Lahuerta Juan José⁵¹⁰,San Miguel Jesús F.⁴⁵¹¹,González Marcos¹²⁴,Mateos María Victoria¹²⁴⁵,Bourdon Jean‐Christophe¹²,Misiewicz‐Krzeminska Irena¹²¹³^ORCID,Gutiérrez Norma C.¹²⁴⁵^ORCID

Affiliation:

1. Hematology Department University Hospital of Salamanca, IBSAL Salamanca Spain

2. Cancer Research Center‐IBMCC (USAL‐CSIC) Salamanca Spain

3. Department of Nanobiotechnology and Experimental Ecology, Institute of Biology Warsaw University of Life Sciences Warsaw Poland

4. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CB16/12/00233 Salamanca Spain

5. Grupo Español de Mieloma (GEM) Barcelona Spain

6. Medicine Department Complutense University Madrid Spain

7. Spanish National Cancer Research Center (CNIO) Madrid Spain

8. University Hospital Germans Trias i Pujol Barcelona Spain

9. Hospital Clinic of Barcelona Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Barcelona Spain

10. Hematology Department University Hospital 12 de Octubre Madrid Spain

11. Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas (CIMA) Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain

12. School of Medicine University of Dundee Dundee UK

13. Experimental Hematology Department Institute of Hematology and Transfusion Medicine Warsaw Poland

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26507

Reference42 articles.

1. Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

2. Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications

3. p53 haploinsufficiency and functional abnormalities in multiple myeloma